ai drug design
METANOVA LABS is a crypto-native biotech company at the forefront of drug discovery. We are developing next generation therapeutics that regulate mental states and restore critical biological processes.
Powered by the Bittensor network, our decentralized drug screening subnet harnesses global compute and collective intelligence to navigate huge unexplored chemical spaces, uncovering breakthrough compounds with unmatched efficiency. We are developing AI tools not just to accelerate our own R&D but to empower medical innovation by all.
reprogramming body + mind
We move beyond a disease-centric view of human health by tapping into the neurosignaling pathways that shape how we think, feel, and live. We’re on a mission to develop innovative small molecules that get to the foundations of health.
Our meta‑programming drugs operate at the source, unlocking the hidden dynamics of our biology to foster lasting change. our mission is to rewrite the rules of drug discovery by:
unlocking a deeper, more intelligent approach to healing and human potential
Traditional drug development is slow, expensive, and often siloed. We believe the future of medicine lies in open, incentive‑driven collaboration, where breakthroughs happen faster, cheaper, and in full view of the community. Our goal isn’t just to treat symptoms—it’s to optimize the underlying biological networks that define our health.
introducing
NOVA
global, decentralized engine for drug discovery
we are building
first-in-class tokenized libraries of the most promising molecules ready for synthesis
with the power of market-driven global competition
JOIN US
-
![]()
Micaela Bazo
CEO
-
![]()
Pedro Penna, PhD
CSO
-
![]()
Amanda Casadei
CTO
